A Review Of The Changing Trends And Use Of eCOA In Clinical Trials

The digital transformation of electronic clinical outcome assessments (eCOAs) is being propelled by factors such as the advent of new technology, the maturation of digital organizations, and increased endorsement from regulatory bodies. Sponsors can capitalize on the advantages offered by flexible and integrated eCOA tools, resulting in expedited study start-up times, improved data quality, enhanced study management efficiencies, superior patient-reporting experiences, and cost savings.

This white paper delves into the industry and regulatory trends converging to drive the broader adoption of eCOA in clinical trials. The latter section of the document presents an overview of Medidata's Rave eCOA, a user-friendly and adaptable solution equipped with a global library of preconfigured and preapproved eCOA questionnaires. Operating on the Medidata Rave Clinical Cloud's unified data platform, it establishes a singular source of truth for all study-related data, facilitating accurate capture of patient outcomes data. These features collectively empower sponsors to utilize Rave eCOA to elevate the patient-reporting experience, fostering trials that prioritize patients while alleviating the burden on sites and clinical teams.